WASHINGTON (Reuters) - The Food and Drug Administration exceeded its authority when it set up a surveillance program to monitor employees in its medical device division who it suspected of leaking trade secrets, two prominent Republican lawmakers said on Wednesday.


Source: Republicans say FDA spying may have broken whistleblower law